BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10066152)

  • 1. The rational use of platelet transfusions in children.
    Cahill MR; Lilleyman JS
    Semin Thromb Hemost; 1998; 24(6):567-75. PubMed ID: 10066152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of leukocyte and platelet administration in cancer therapy.
    Walker EM; Cannon A; Mitchum EN
    Ann Clin Lab Sci; 1983; 13(6):453-73. PubMed ID: 6197928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supportive care for children with cancer. Guidelines of the Childrens Cancer Study Group. The use of platelet transfusions.
    Feusner J
    Am J Pediatr Hematol Oncol; 1984; 6(3):255-60. PubMed ID: 6393789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing platelet transfusion therapy.
    Heal JM; Blumberg N
    Blood Rev; 2004 Sep; 18(3):149-65. PubMed ID: 15183900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
    Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D
    Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses.
    Arnold DM; Crowther MA; Cook RJ; Sigouin C; Heddle NM; Molnar L; Cook DJ
    Transfusion; 2006 Aug; 46(8):1286-91. PubMed ID: 16934061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current practice and future directions for optimization of platelet transfusions in patients with severe therapy-induced cytopenia.
    Apelseth TO; Hervig T; Bruserud O
    Blood Rev; 2011 May; 25(3):113-22. PubMed ID: 21316823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L.
    Nevo S; Fuller AK; Hartley E; Borinsky ME; Vogelsang GB
    Transfusion; 2007 May; 47(5):801-12. PubMed ID: 17465944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence-based platelet transfusion recommendations in neonates.
    Del Vecchio A; Motta M
    J Matern Fetal Neonatal Med; 2011 Oct; 24 Suppl 1():38-40. PubMed ID: 21878062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet transfusions in infants with necrotizing enterocolitis.
    Fernandes CJ; O'Donovan DJ
    Curr Hematol Rep; 2006 Mar; 5(1):76-81. PubMed ID: 16537050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet transfusion. Current techniques, remaining problems, and future prospects.
    Herman JH; Kamel HT
    Am J Pediatr Hematol Oncol; 1987; 9(3):272-86. PubMed ID: 3314551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal thrombocytopenia: what we do and don't know.
    Sola-Visner M; Saxonhouse MA; Brown RE
    Early Hum Dev; 2008 Aug; 84(8):499-506. PubMed ID: 18684573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet transfusion therapy.
    Slichter SJ
    Hematol Oncol Clin North Am; 2007 Aug; 21(4):697-729, vii. PubMed ID: 17666286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet utilization and the transfusion trigger: a prospective analysis.
    Greeno E; McCullough J; Weisdorf D
    Transfusion; 2007 Feb; 47(2):201-5. PubMed ID: 17302764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet transfusions in infants with necrotizing enterocolitis do not lower mortality but may increase morbidity.
    Kenton AB; Hegemier S; Smith EO; O'Donovan DJ; Brandt ML; Cass DL; Helmrath MA; Washburn K; Weihe EK; Fernandes CJ
    J Perinatol; 2005 Mar; 25(3):173-7. PubMed ID: 15578029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The platelet-refractory bone marrow transplant patient: prophylaxis and treatment of bleeding.
    Benson K; Fields K; Hiemenz J; Zorsky P; Ballester O; Perkins J; Elfenbein G
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):102-9. PubMed ID: 8211211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation.
    Toor AA; Choo SY; Little JA
    Bone Marrow Transplant; 2000 Aug; 26(3):315-20. PubMed ID: 10967572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing platelet mass versus platelet count to guide platelet transfusions in the neonatal intensive care unit.
    Gerday E; Baer VL; Lambert DK; Paul DA; Sola-Visner MC; Pysher TJ; Christensen RD
    Transfusion; 2009 Oct; 49(10):2034-9. PubMed ID: 19555422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Very high users of platelet transfusions in the neonatal intensive care unit.
    Dohner ML; Wiedmeier SE; Stoddard RA; Null D; Lambert DK; Burnett J; Baer VL; Hunt JC; Henry E; Christensen RD
    Transfusion; 2009 May; 49(5):869-72. PubMed ID: 19175546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet transfusion in the neonatal intensive care unit: benefits, risks, alternatives.
    Christensen RD
    Neonatology; 2011; 100(3):311-8. PubMed ID: 21986337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.